Why the study?
New ESC guidelines on chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia, and dyslipidaemias were published in 2019 requiring dissemination and implementation.
Summarizes the 2019 ESC guidelines on chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia, and dyslipidaemias to enhance clinical implementation.
Prompts integration of 2019 ESC recommendations into patient care; extends prior guidelines for ongoing research refinement.
During the ESC congress in September 2019 in Paris, the new ESC guidelines were presented and are now available on the ESC website. The new guidelines describe management recommendations on following cardiovascular diseases: chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia and dislipidaemias. The present document gives a summary of these guidelines and highlights the most important recommendations and changes in the management of these diseases. It will help to increase awareness about the new guidelines and may stimulate to consult the full document for specific items. Ultimately, the authors hope that this document will enhance implementation of new ESC guidelines in daily clinical practice.
No takes yet. Share an insight, caveat, or question.
Claeys et al. (2020) conducted a review in Cardiovascular diseases (chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia, dyslipidaemias). 2019 ESC Guidelines was evaluated. The 2019 ESC guidelines provide updated recommendations for the diagnosis and management of chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia, and dyslipidaemias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: